Natriuretic peptides and endothelin-1 in patients undergoing coronary artery bypass grafting

K Danová1, I Pechán, I Olejárová

  • 1Department of Laboratory Medicine, National Institute of Cardiovascular Diseases, Bratislava, Slovakia. katarina.danova@nusch.sk

Insights

Off-pump coronary artery bypass grafting (CABG) reduces complications. This study found off-pump CABG did not alter atrial natriuretic peptide (ANP) or brain natriuretic peptide (BNP) levels, but significantly lowered endothelin-1 (ET-1) compared to on-pump surgery.

Area of Science:

  • Cardiovascular Surgery
  • Vascular Biology
  • Surgical Outcomes

Background:

  • Coronary artery bypass grafting (CABG) is a common cardiac surgery.
  • Conventional CABG utilizes cardiopulmonary bypass, associated with potential complications.
  • Off-pump CABG (OPCAB) is an alternative surgical technique aiming to mitigate these risks.

Purpose of the Study:

  • To compare the peri- and postoperative levels of vasoactive peptides in patients undergoing OPCAB versus conventional on-pump CABG.
  • To investigate the impact of different CABG techniques on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), and endothelin-1 (ET-1).

Main Methods:

  • A comparative study involving 22 patients undergoing CABG.
  • Patients were divided into two groups: on-pump CABG (n=11) and off-pump CABG (n=11).
  • Plasma levels of ANP, BNP, and ET-1 were measured perioperatively and postoperatively.

Main Results:

  • Perioperative and postoperative plasma levels of ANP and BNP were similar between the on-pump and off-pump CABG groups.
  • A statistically significant difference in ET-1 plasma levels was observed 2 hours after surgery between the groups (p < 0.0001).
  • Plasma ET-1 levels significantly increased in the on-pump CABG group, suggesting potential endothelial damage.

Conclusions:

  • The choice between on-pump and off-pump CABG does not significantly affect peri- and postoperative ANP and BNP levels.
  • Off-pump CABG is associated with significantly lower ET-1 levels post-surgery compared to on-pump CABG.
  • The elevated ET-1 levels in the on-pump group may indicate greater endothelial injury during cardiopulmonary bypass.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...